SIBNSI-BONE, Inc.
Is it safe?
Caution warranted: heavy debt (CCC) and big price swings.
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -69% · now 12% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can SIBN take a bad year?
The deepest fall in SIBN's price history on file is −69%; it is 12% below its high today.
Net debt · as at Q2 2026 · debt less the cash on hand, with no positive EBITDA to service it
- Cash runway
- 5+ years
Cash runway · burning $1.1M a quarter at the current rate
- Annualised volatility
- 52%
Annualised volatility · roughly twice as jumpy as the market
- Worst drawdown on file
- −69%
Worst drawdown on file · −12% today
Details›
- Total debtQ2 2026
- $36M
- Cash and short-term investments
- $33M
- Net debt
- $2.5M
- EBITDA, trailing twelve months
- −$11M
- Operating profit, trailing twelve months
- −$18M
- Debt / equity
- 0.20×
- Annualised volatilitytwo years of daily moves
- 52%
- Worst drawdown on file
- −69%
- Below its 52-week high
- 12%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Devices
Ranks #38 of 51 by RyuScore